ANSI/ANAB Accredits Quality Certification Services

ANSI/ANAB Accredits Quality Certification Services

The American National Standards Institute (ANSI), coordinator of the U.S. voluntary standardization system, has accredited Florida Certified Organic Growers, Inc. DBA Quality Certification Services in accordance with the international standard ISO/IEC 17065, Conformity assessment—Requirements for bodies certifying products, processes, and services; and pertinent certification scheme requirements and regulations under the U.S. Food & Drug Administration (FDA)’s Food Safety Modernization Act, or FSMA. ANSI’s conformity assessment accreditation programs were reorganized in December 2018 under the ANSI National Accreditation Board (ANAB) brand, a wholly owned subsidiary of ANSI.

Silicon Wafer Shipments Drop to Lowest Level Since Fourth Quarter of 2017

Silicon Wafer Shipments Drop to Lowest Level Since Fourth Quarter of 2017

Worldwide silicon wafer area shipments dropped 5.6 percent during the first quarter 2019 when compared to the fourth quarter 2018 and are now at their lowest level since the fourth quarter of 2017 after silicon wafer shipments for the most recent quarter declined 1 percent quarter-over-quarter, according to the SEMI Silicon Manufacturers Group (SMG) in its quarterly analysis of the silicon wafer industry.

Global Semiconductor Equipment Sales

Global Semiconductor Equipment Sales

Worldwide sales of semiconductor manufacturing equipment surged 14 percent from $56.62 billion in 2017 to an all-time high of $64.5 billion in 2018, SEMI, the industry association representing the worldwide electronics product design and manufacturing supply chain, reported today.

Particle Robotic System

Particle Robotic System

Taking a cue from biological cells, researchers from MIT, Columbia University, and elsewhere have developed computationally simple robots that connect in large groups to move around, transport objects, and complete other tasks.

New Stem Cell Gene Therapy Facility

New Stem Cell Gene Therapy Facility

Stem Cell Medicine Ltd. (SCM), a biotechnology company developing new therapies for neurological indications and rare diseases through gene therapy, cell therapy, exosomes, novel molecules and combinations with existing pharmaceuticals, announced today that it has received funding from the Israeli Ministry of the Economy to build a gene therapy facility.